The following inhibitors were used: β-secretase inhibitor II (BSI, Calbiochem, 1 μM), GM6001 (Calbiochem, 5 μM), TAPI-1 (Calbiochem, 1 μM), DAPT (Calbiochem, 1 μM), BI2536 (Axon MedChem, 50 nM), APV (Tocris Bioscience, 50 μM), CNQX (Tocris Bioscience, 40 μM) or phosphatase inhibitor I and II (Sigma). PTX was freshly prepared as a 10 mM stock in 0.1 M NaOH and used at 25 μM final concentration.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.